KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Short-Term Debt issuances (2016 - 2025)

Cvs Health (CVS) has disclosed Short-Term Debt issuances for 16 consecutive years, with $872.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances rose 245.33% year-over-year to $872.0 million, compared with a TTM value of -$1.5 billion through Sep 2025, down 126.29%, and an annual FY2023 reading of $5.0 billion, changed N/A over the prior year.
  • Short-Term Debt issuances was $872.0 million for Q4 2025 at Cvs Health, up from -$1.8 billion in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $5.0 billion in Q4 2023 and bottomed at -$2.7 billion in Q2 2024.
  • Average Short-Term Debt issuances over 4 years is $437.7 million, with a median of $526.0 million recorded in 2021.
  • The sharpest move saw Short-Term Debt issuances crashed 371.9% in 2024, then skyrocketed 245.33% in 2025.
  • Year by year, Short-Term Debt issuances stood at $252.0 million in 2021, then surged by 1884.13% to $5.0 billion in 2023, then tumbled by 112.0% to -$600.0 million in 2024, then surged by 245.33% to $872.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for CVS at $872.0 million in Q4 2025, -$1.8 billion in Q3 2025, and $1.8 billion in Q2 2025.